SLU-PP-332: molecular data, studies & sources

Molecular formula, weight & structure

Molecular formula (MF)

C18H14N2O2

Molecular weight (MW)

290.3 g/mol

PubChem compound ID

5338394

Record title

Slu-PP-332

Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.

Source: PubChem CID 5338394 · retrieved 2026-09-21

Registered clinical trials

Studies registered on ClinicalTrials.gov that list SLU-PP-332 as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.

No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.

Registry check 2026-10-01 · Run this search on ClinicalTrials.gov

Human intervention studies

Selected studies in which participants received SLU-PP-332, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.

No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

1. Research publication · design requires review

   Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling.

   Okda HE, Zhao P, Hayes M et al. · International journal of biological macromolecules · 2026

   PMID 41850449 · DOI: 10.1016/j.ijbiomac.2026.151450

2. Research publication · design requires review

   In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.

   Möller T, Krug O, Thevis M et al. · Rapid communications in mass spectrometry : RCM · 2026

   PMID 41588687 · DOI: 10.1002/rcm.70039

3. Research publication · design requires review

   Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.

   Avliyakulov NK, Sobolevsky T, Ahrens E et al. · Drug testing and analysis · 2026

   PMID 41688415 · DOI: 10.1002/dta.70035

SLU-PP-332 supplier sources

Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

SLU-PP-332 for sale: compare prices, sizes and forms from every tracked supplier →

Reference sources & further reading

• PubChem compound record 5338394 — chemical identity and structure.
• Wikipedia: SLU-PP-332 — Background encyclopedia; not a primary clinical source.

The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

Related research profiles